UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions

Value in health, 2019-11, Vol.22 (11), p.1275-1282

2019

Volltextzugriff (PDF)

Statins, systemic inflammation and risk of death in COPD: The Rotterdam study

Pulmonary pharmacology & therapeutics, 2013-04, Vol.26 (2), p.212-217

2013

Volltextzugriff (PDF)

Methods to assess intended effects of drug treatment in observational studies are reviewed

Journal of clinical epidemiology, 2004-12, Vol.57 (12), p.1223-1231

2004

Volltextzugriff (PDF)

Use of metformin and survival of diabetic women with breast cancer

Current drug safety, 2013-11, Vol.8 (5), p.357-363

2013

Volltextzugriff (PDF)

Mortality in British hip fracture patients, 2000–2010: A population-based retrospective cohort study

Bone (New York, N.Y.), 2014-09, Vol.66, p.171-177

2014

Volltextzugriff (PDF)

Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Value in health, 2012-07, Vol.15 (5), p.664-673

2012

Volltextzugriff (PDF)

Global Regulatory Differences for Gene‐ and Cell‐Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation

Clinical pharmacology and therapeutics, 2018-01, Vol.103 (1), p.120-127

2018

Volltextzugriff (PDF)

Drug Repurposing for Rare Diseases: A Role for Academia

Frontiers in pharmacology, 2021-10, Vol.12, p.746987-746987

2021

Volltextzugriff (PDF)

Use of thiazolidinediones and risk of bladder cancer: disease or drugs?

Current drug safety, 2013-11, Vol.8 (5), p.364-370

2013

Volltextzugriff (PDF)

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture

Bone (New York, N.Y.), 2014-11, Vol.68, p.124-130

2014

Volltextzugriff (PDF)

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Molecular therapy. Methods & clinical development, 2018-12, Vol.11, p.121-130

2018

Volltextzugriff (PDF)

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

Bone (New York, N.Y.), 2010-09, Vol.47 (3), p.604-609

2010

Volltextzugriff (PDF)

Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2266-2272

2011

Volltextzugriff (PDF)

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

Journal of clinical epidemiology, 2017-08, Vol.88, p.140-147

2017

Volltextzugriff (PDF)

Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study

Journal of clinical epidemiology, 2017-09, Vol.89, p.199-208

2017

Volltextzugriff (PDF)

Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities

Clinical interventions in aging, 2019-01, Vol.14, p.535-547

2019

Volltextzugriff (PDF)

Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries

Health policy (Amsterdam), 2013-10, Vol.112 (3), p.209-216

2013

Volltextzugriff (PDF)

The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges

Current drug safety, 2013-11, Vol.8 (5), p.371-378

2013

Volltextzugriff (PDF)

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder

Prostaglandins, leukotrienes and essential fatty acids, 2010-01, Vol.82 (1), p.9-14

2010

Volltextzugriff (PDF)

International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia

Journal of clinical epidemiology, 2007-08, Vol.60 (8), p.834-838

2007

Volltextzugriff (PDF)

Factors influencing non-approval of new drugs in Europe

Nature reviews. Drug discovery, 2012-12, Vol.11 (12), p.903-904

2012

Volltextzugriff (PDF)

Pharmacovigilance of Biopharmaceuticals: Challenges Remain

Drug safety, 2009-10, Vol.32 (10), p.811-817

2009

Volltextzugriff (PDF)

5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1733-1739

2004

Volltextzugriff (PDF)

Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab

Drug discovery today, 2013-09, Vol.18 (17-18), p.872-879

2013

Volltextzugriff (PDF)

Switching TNFα inhibitors: Patterns and determinants

Pharmacology research & perspectives, 2021-08, Vol.9 (4), p.e00843-n/a

2021

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(250)

Publikationsform

Artikel
(289)
Buchkapitel
(2)

Sprache

Englisch
(291)

Erscheinungsjahr

n.n

Thema

Science & Technology
(260)
Life Sciences & Biomedicine
(252)
Humans
(217)
Pharmacology & Pharmacy
(126)
Female
(123)
Male
(115)
Middle Aged
(103)
Aged
(87)
Biological And Medical Sciences
(84)
Medical Sciences
(84)
Adult
(81)
Risk Factors
(61)
Public, Environmental & Occupational Health
(54)
Pharmacology. Drug Treatments
(53)
Adolescent
(50)
Cohort Studies
(50)
Aged, 80 And Over
(46)
Case-Control Studies
(45)
Netherlands
(40)
Medicine
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions

Statins, systemic inflammation and risk of death in COPD: The Rotterdam study

Methods to assess intended effects of drug treatment in observational studies are reviewed

Use of metformin and survival of diabetic women with breast cancer

Mortality in British hip fracture patients, 2000–2010: A population-based retrospective cohort study

Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?

Global Regulatory Differences for Gene‐ and Cell‐Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation

Drug Repurposing for Rare Diseases: A Role for Academia

Use of thiazolidinediones and risk of bladder cancer: disease or drugs?

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice

Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands

Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study

Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities

Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries

The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges

Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder

International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia

Factors influencing non-approval of new drugs in Europe

Pharmacovigilance of Biopharmaceuticals: Challenges Remain

5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study

Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab

Switching TNFα inhibitors: Patterns and determinants

Suchergebnisse filtern